Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DSM Entering U.S. Via Catalytica: European Bulk Firms Going Global

Executive Summary

DSM plans to establish a U.S. presence for its bulk active ingredient and contract manufacturing operations through the acquisition of Catalytica Pharmaceuticals.

You may also be interested in...



Aptuit Eyes Biologics Production After Buying Clinical Trial Material Suppliers

Aptuit plans to purchase biologics pilot manufacturing and protein development capabilities as part of the continuing expansion strategy for the drug development service provider

Aptuit Eyes Biologics Production After Buying Clinical Trial Material Suppliers

Aptuit plans to purchase biologics pilot manufacturing and protein development capabilities as part of the continuing expansion strategy for the drug development service provider

DSM Submits “Final” GMP Report To FDA; New Quality Systems In Place

DSM Pharmaceuticals is highlighting new environmental monitoring systems in its response to FDA about recent good manufacturing practices inspections

Related Content

UsernamePublicRestriction

Register

PS036489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel